相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Medical treatment of pulmonary hypertension in adults with congenital heart disease: updated and extended results from the International COMPERA-CHD Registry
Ann-Sophie Kaemmerer et al.
CARDIOVASCULAR DIAGNOSIS AND THERAPY (2021)
Efficacy and safety of pulmonary vasodilators in the patients with Eisenmenger syndrome: a meta-analysis of randomized controlled trials
Yulin Hou et al.
PULMONARY CIRCULATION (2021)
Improved low-risk criteria scores for combination therapy of sildenafil and generic bosentan in patients with congenital heart disease with severe pulmonary hypertension: A prospective open label study
Kritvikrom Durongpisitkul et al.
JRSM CARDIOVASCULAR DISEASE (2021)
Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension A Double-Blind Placebo-controlled Clinical Trial
R. James White et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Pulmonary Hypertension in Adults with Congenital Heart Disease: Real-World Data from the International COMPERA-CHD Registry
Harald Kaemmerer et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The effect of oral sildenafil therapy on health-related quality of life in adults with pulmonary arterial hypertension related to uncorrected secundum atrial septal defect: a quasi experimental study
Fera Hidayati et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2020)
Guideline implementation and early risk assessment in pulmonary arterial hypertension associated with congenital heart disease: A retrospective cohort study
Xiaoxian Deng et al.
CLINICAL RESPIRATORY JOURNAL (2019)
The effects of parenteral prostacyclin therapy as add-on treatment to oral compounds in Eisenmenger syndrome
Michele D'Alto et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Evaluation of Macitentan in Patients With Eisenmenger Syndrome Results From the Randomized, Controlled MAESTRO Study
Michael A. Gatzoulis et al.
CIRCULATION (2019)
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Gerald Simonneau et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Risk assessment in pulmonary arterial hypertension
Marius M. Hoeper et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
From bosentan to macitentan for pulmonary arterial hypertension and adult congenital heart disease: Further improvement?
Ilja M. Blok et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Effects of long-term iloprost treatment on right ventricular function in patients with Eisenmenger syndrome
Min Ku Chon et al.
JOURNAL OF CARDIOLOGY (2017)
Pulmonary arterial hypertension associated with congenital heart disease: Comparison of clinical and anatomic-pathophysiologic classification
Sheila Ramjug et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2016)
Effect of dual pulmonary vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease: a retrospective analysis
Oliver Monfredi et al.
OPEN HEART (2016)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Nazzareno Galie et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension
Vallerie McLaughlin et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Riociguat for pulmonary arterial hypertension associated with congenital heart disease
Stephan Rosenkranz et al.
HEART (2015)
Selexipag for the Treatment of Pulmonary Arterial Hypertension
Olivier Sitbon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
N. Galie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups
Alessandra Manes et al.
EUROPEAN HEART JOURNAL (2014)
Randomized study of adding tadalafil to existing ambrisentan in pulmonary arterial hypertension
Yugang Zhuang et al.
HYPERTENSION RESEARCH (2014)
Pulmonary arterial hypertension associated with congenital heart disease: Recent advances and future directions
Michael A. Gatzoulis et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Effects of Inhaled Iloprost on Exercise Capacity, Quality of Life, and Cardiac Function in Patients With Pulmonary Arterial Hypertension Secondary to Congenital Heart Disease (the Eisenmenger Syndrome) (from the EIGER Study)
Kwang Soo Cha et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients Receiving Background Endothelin Receptor Antagonist and Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C2 Study) A Randomized Controlled Trial
Victor F. Tapson et al.
CHEST (2013)
Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension A Randomized, Controlled Trial
Zhi-Cheng Jing et al.
CIRCULATION (2013)
Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension Results of the Randomized IMPRES Study
Marius M. Hoeper et al.
CIRCULATION (2013)
Therapy for pulmonary arterial hypertension due to congenital heart disease and Down's syndrome
Michele D'Alto et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Impact of Sildenafil on Survival of Patients With Eisenmenger Syndrome
Yun-Juan Sun et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
Tomas Pulido et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Modern Age Pathology of Pulmonary Arterial Hypertension
Elvira Stacher et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C Study) A Randomized Controlled Trial
Victor E. Tapson et al.
CHEST (2012)
Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension
Gerald Simonneau et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology
Michele D'Alto et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
Effects of Inhaled Iloprost on Congenital Heart Disease With Eisenmenger Syndrome
Song I. Yang et al.
PEDIATRIC CARDIOLOGY (2012)
Ambrisentan for Pulmonary Arterial Hypertension Due to Congenital Heart Disease
Warren A. Zuckerman et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Vardenafil in Pulmonary Arterial Hypertension A Randomized, Double-blind, Placebo-controlled Study
Zhi-Cheng Jing et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Comparative efficacy of sildenafil in Eisenmenger's syndrome secondary to atrial septal defect versus ventricular septal defect: a cardiac catheterisation follow-up study
Naveen Garg et al.
CARDIOLOGY IN THE YOUNG (2011)
The Efficacy and Safety of Sildenafil in Patients With Pulmonary Arterial Hypertension Associated With the Different Types of Congenital Heart Disease
Wei-Jie Zeng et al.
CLINICAL CARDIOLOGY (2011)
Oral sildenafil treatment for Eisenmenger syndrome: a prospective, open-label, multicentre study
Zhen-Ning Zhang et al.
HEART (2011)
Quality of life and functional capacity can be improved in patients with Eisenmenger syndrome with oral sildenafil therapy
Edgar L. W. Tay et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Diagnosis of Pulmonary Hypertension in the Congenital Heart Disease Adult Population Impact on Outcomes
Boris S. Lowe et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Clinical Efficacy of Phosphodiesterase-5 Inhibitor Tadalafil in Eisenmenger Syndrome-A Randomized, Placebo-controlled, Double-blind Crossover Study
Saibal Mukhopadhyay et al.
CONGENITAL HEART DISEASE (2011)
Anatomical and pathophysiological classification of congenital heart disease
Gaetano Thiene et al.
CARDIOVASCULAR PATHOLOGY (2010)
Improved Survival Among Patients With Eisenmenger Syndrome Receiving Advanced Therapy for Pulmonary Arterial Hypertension
Konstantinos Dimopoulos et al.
CIRCULATION (2010)
Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial
Kasper Iversen et al.
EUROPEAN HEART JOURNAL (2010)
Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: A subgroup analysis
Rolf M. F. Berger et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Effect of Bosentan on Exercise Capacity and Quality of Life in Adults With Pulmonary Arterial Hypertension Associated With Congenital Heart Disease With and Without Down's Syndrome
Marielle G. J. Duffels et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial (vol 149, pg 521, 2008)
G. Simonneau et al.
ANNALS OF INTERNAL MEDICINE (2009)
Tadalafil Therapy for Pulmonary Arterial Hypertension
Nazzareno Galie et al.
CIRCULATION (2009)
A Blue Baby Grows Up
Jamil A. Aboulhosn et al.
CONGENITAL HEART DISEASE (2009)
Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome:: Results of the BREATHE-5 open-label extension study
Michael A. Gatzoulis et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension A Randomized Trial
Gerald Simonneau et al.
ANNALS OF INTERNAL MEDICINE (2008)
Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension
Elaine M. C. Chau et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Role of oral sildenafil in severe pulmonary arterial hypertension: Clinical efficacy and dose response relationship
Naveen Garg et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Long-term oral bosentan treatment in patients with pulmonary arterial hypertension related to congenital heart disease: a 2-year study
S. C. Apostolopoulou et al.
HEART (2007)
Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension
Vallerie V. McLaughlin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Phosphodiesterase-5 inhibitor in Eisenmenger syndrome - A preliminary observational study
Saibal Mukhopadhyay et al.
CIRCULATION (2006)
Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects
O. Sitbon et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2006)
Bosentan therapy in patients with Eisenmenger syndrome - A multicenter, double-blind, randomized, placebo-controlled study
Nazzareno Galie et al.
CIRCULATION (2006)
Bosentan for the treatment of pulmonary arterial hypertension associated with congenital cardiac disease
Eugene Kotlyar et al.
CARDIOLOGY IN THE YOUNG (2006)
A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension
TP Singh et al.
AMERICAN HEART JOURNAL (2006)
Sildenafil citrate therapy for pulmonary arterial hypertension
N Galiè et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease
SC Apostolopoulou et al.
HEART (2005)
Initial experience with Bosentan therapy in patients with the Eisenmenger syndrome
DD Christensen et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Usefulness of epoprostenol therapy in the severely ill adolescent/adult with Eisenmenger physiology
SM Fernandes et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension - A double-blind, randomized, placebo-controlled trial
G Simonneau et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Congenital heart disease in adults: First of two parts
ME Brickner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
